Wei-jun J. Fan

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial.

Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 24, 2026

Co-Ablation System for Pain Management in Bone Metastases: Retrospective Exploratory Study.

Co-Ablation System for Pain Management in Bone Metastases: Retrospective Exploratory Study.

Journal: JMIR cancer

Published: October 22, 2025

TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysis.

TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysis.

Journal: European radiology experimental

Published: July 31, 2025

Long-term outcomes of ablation versus surgery in patients with colorectal carcinoma pulmonary oligometastases: a single-center, retrospective cohort study.

Long-term outcomes of ablation versus surgery in patients with colorectal carcinoma pulmonary oligometastases: a single-center, retrospective cohort study.

Journal: International journal of surgery (London, England)

Published: May 09, 2025

Microwave ablation combined with transarterial embolization for retroperitoneal inflammatory myofibroblastic tumor: A case report on complete response.

Microwave ablation combined with transarterial embolization for retroperitoneal inflammatory myofibroblastic tumor: A case report on complete response.

Journal: Journal of cancer research and therapeutics

Published: June 03, 2024

Correction: The important role of whole-process computed tomography guidance for percutaneous gastrostomy in esophageal cancer patients who are unsuitable for or have had unsuccessful attempts with endoscopic and fuoroscopic gastrostomy.

Correction: The important role of whole-process computed tomography guidance for percutaneous gastrostomy in esophageal cancer patients who are unsuitable for or have had unsuccessful attempts with endoscopic and fuoroscopic gastrostomy.

Journal: BMC gastroenterology

Published: February 26, 2024

Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.

Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.

Journal: Hepatology international

Published: July 07, 2023

The important role of whole-process computed tomography guidance for percutaneous gastrostomy in esophageal cancer patients who are unsuitable for or have had unsuccessful attempts with endoscopic and fluoroscopic gastrostomy.

The important role of whole-process computed tomography guidance for percutaneous gastrostomy in esophageal cancer patients who are unsuitable for or have had unsuccessful attempts with endoscopic and fluoroscopic gastrostomy.

Journal: BMC gastroenterology

Published: March 26, 2023

Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.

Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.

Journal: Clinical and translational gastroenterology

Published: December 07, 2022

Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinoma.

Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: August 08, 2022

Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas.

Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas.

Journal: Frontiers in oncology

Published: June 24, 2022

Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety.

Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety.

Journal: Frontiers in oncology

Published: June 23, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026